Om avsnittet
It's estimated only one percent of medical research spending globally goes toward female-specific conditions that aren't related to cancer. But even as underfunding of women's health persists -- companies focused on women's health are innovating. Dr. Sara Naseri is working to reframe menstrual blood as a diagnostic tool rather than waste, with her company called Qvin. It received FDA clearance in January of this year for a new kind of blood test: a diagnostic menstrual pad. Plus, Axios senior health care editor Adriel Bettelheim on innovations in women's health. Guests: Dr. Sara Naseri, CEO and co-founder of Qvin; Axios' Adriel Bettelheim Credits: 1 big thing is produced by Niala Boodhoo, Alexandra Botti, and Jay Cowit. Music is composed by Alex Sugiura and Jay Cowit. You can reach us at podcasts@axios.com. You can send questions, comments and story ideas as a text or voice memo to Niala at 202-918-4893. Learn more about your ad choices. Visit megaphone.fm/adchoices
Senaste avsnitten
Fei-Fei Li: AI's new possibilities for robots
Rep. Miller-Meeks: The GOP can lead on climate change
Sue Bird: "Society finally caught up" with women's basketball
Avril Benoît: Is ignoring humanitarian law the new norm?
Duncan McIntyre: Electrifying school bus fleets
Anna Hehir: Banning the most dangerous autonomous weapons
Alondra Nelson: AI chatbots get elections info wrong
Sen. Joe Manchin: What's at stake when we lose the center